Northwest Biotherapeutics (NWBO) Net Margin Growth (5y) (2015 - 2026)
Northwest Biotherapeutics (NWBO) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103,685.00 |
| Dec 31, 2025 | 5.59 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Jun 30, 2025 | 289.04 Mn |
| Mar 31, 2025 | -568,950.00 |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | -441,125.00 |
| Jun 30, 2024 | -362,789.00 |
| Mar 31, 2024 | -46,913.00 |
| Dec 31, 2023 | -447,030.00 |
| Sep 30, 2023 | -777,640.00 |
| Jun 30, 2023 | 144,294.00 |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 8.36 Mn |
| Sep 30, 2022 | -22,392.00 |
| Jun 30, 2022 | 543,143.00 |
| Mar 31, 2022 | 1.50 Mn |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 1.18 Mn |
| Mar 31, 2021 | 598,549.00 |